drugset / Trial / NCT04064840
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
RandomizedParallel-groupTriple-blindTreatment
Summary
The objectives of this study are to compare the efficacy of the dual trigger group vs the hCG trigger group on the live birth rate in women undergoing IVF and the efficacy of the agonist in LP group vs the placebo group on the live birth rate in women undergoing FET.
Timeline
- Start
- 2019-09-01
- Primary completion
- 2024-09-01
- Completion
- 2026-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Decapeptyl | Unknown | 0.1 mg | Subcutaneous |
| Comparator | Decapeptyl | Unknown | 0.2 mg | Subcutaneous |
| Comparator | hCG | Unknown | 0.25 mg | Subcutaneous |